| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC562 | |||||||||||||||||||||||
| Submitter : | Ms. Barbara Evans | Date & Time: | 01/04/2007 08:01:57 | |||||||||||||||||||||
| Organization : | Ms. Barbara Evans | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| As a very satisfied Obaji product user I am dismayed to find you are considering withdrawing hydroquinone from the market. Unless you have absolute proof that this drug, as currently used topically, is harmful, please leave it on the market. I think the Obaji system is terrific. My skin is much healthier; I have fewer dermatology appointments to remove brown spots; and it seems to effectively slow/prevent the formation of new brown spots. Please do not change the status of this drug. | ||||||||||||||||||||||||